10:25 EST 11th December 2018 | BioPortfolio

Here are the most relevant search results for "LUNAR DREAM CAPSULE PROJECT" found in our extensive news archives from over 250 global news sources.

More Information about LUNAR DREAM CAPSULE PROJECT on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about LUNAR DREAM CAPSULE PROJECT for you to read. Along with our medical data and news we also list LUNAR DREAM CAPSULE PROJECT Clinical Trials, which are updated daily. BioPortfolio also has a large database of LUNAR DREAM CAPSULE PROJECT Companies for you to search.

Showing "LUNAR DREAM CAPSULE PROJECT" News Articles 1–25 of 3,000+

Tuesday 11th December 2018

AstraZeneca Healthcare Foundation Awards over $1.16 Million to 11 Innovative Heart Health Programs

Eleven community-based heart health programs with innovative approaches to help prevent and control heart disease received grants totaling over $1.16 million from the AstraZeneca HealthCare Foundation’s Connections for Cardiovascular HealthSM program. For the ninth year, the Foundation is awarding grants to nonprofit organizations addressing the...

Healx Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryHealx Ltd Healx is a provider of drug repurposing solutions and combinational medicines for advancing the treatment of rare diseases. The company's technology combines biological data analysis with advanced machine learning algorithms to identify novel drug applications for rare diseases. It offers Rareomics, a tool that helps researchers, charities, and individuals keep up with the latest ...

Team Novo Nordisk Adds Five New Riders to 2019 Pro Roster

The world’s first all-diabetes pro cycling team brings in an Olympian and advances four riders from its development squad while adding changes to its GSG-designed jersey ATLANTA (PRWEB) December 11, 2018 Team Novo Nordisk, the world’s first all-diabetes pro cycling team, will race its seventh season with 16 athletes from a dozen countries. The five new riders joining the team include Olympian...

Quotient Sciences Conducts Integrated Translational Pharmaceutics® Program in U.S. with Druggability Technologies

Quotient Sciences, a leading drug development services organization, and Druggability Technologies (DRGT), a specialty pharmaceutical company, announced a collab

Data, Data, Everywhere, But How Much Of It Makes A Real Difference?

Having a single patient's complete health care information all in one place was a dream that US visionaries began to...   

Monday 10th December 2018

Owning the Process

ArticleWhat owners should know when choosing a project delivery method.Contributed Author: Don Crotty, Skanska USA

From Suicidal to Sunny Side of Life: How One Woman Used Her Clinical Depression to Change the Way We Think About Happiness

Faced with a life or death decision she chose life and never looked back. Erica Lester has figured out the key to living life on purpose instead of by default. She now teaches others to do the same through her one-on-one coaching and online training programs. BOISE, Idaho (PRWEB) December 10, 2018 Five years ago, Erica Lester was diagnosed with clinical depression. “I had what looked like a hap...

WuXi AppTec Expands Site in California for Pharmaceutical R&D Services

SAN DIEGO and SHANGHAI, Dec. 10, 2018 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities in San Diego, California. WuXi AppTec's newly expanded facility will establish a center of excellence in screening, discovery biology, pharmacology, and small m...

Pharmacy Times Continuing Education™ Announces The Council for Medication Safety: Mitigating Contamination and Improving the Safe Handling of Hazardous Drugs

The committee will publish a continuing education article in Pharmacy Times® Health-System Edition and Specialty Pharmacy Times® in February 2019 Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health system, managed care and specialty pharmacists, announced The Council for Medication Safety: Mitigat...

Loma Linda University School of Public Health Study Finds Railyard Proximity Linked to Asthma in Children

A study assessing all 18 major freight railyards in California found a link with freight railyard pollution to asthma-related emergency room visits in children. LOMA LINDA, Calif. (PRWEB) December 10, 2018 Loma Linda University School of Public Health researchers released the first study assessing all 18 major freight railyards in California and found a link with freight-railyard pollution to ast...

Health and Health Care Quality Improvers from 56 Countries Gather for IHI’s 30th National Forum

Longest-running gathering on health care quality unveils new resources to broaden and strengthen strategies to improve health and patient care The Institute for Healthcare Improvement (IHI) has opened its 30th

Simpler drug delivery through capsule-based inhalation

Delivery by inhalation could be an easier way to deliver therapies in areas such as oncology, suggested ACGâs development manager.

Difficult Twin Birth Tests Project to Reduce Cesareans

Team Birth Project, a new method created to reduce the number of C-sections, tested by a difficult twin birth. Kaiser Health News

Lyndra Therapeutics Announces Notice of Allowance on Patent Covering Long-acting Pill

Lyndra Therapeutics, which is moving toward making daily pills a thing of the past, today announced a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for intellectual property (IP) related to Lyndra’s ultra-long-acting oral drug delivery system. This indicates that the patent application has cleared internal review and is pending is...

Follicum teams up with University of Bradford on peptide research

 Follicum AB ("Follicum" or "Company"), a biotech company developing  new peptide drugs in two areas, hair loss and diabetes, today reports that it has signed a collaboration agreement with the Centre for Skin Sciences (CSS) at University of Bradford, UK. The aim is to combine in vitro experiments with the use of bioinformatics data mining and analysis to investigat...

Syncroness Gains AS9100 Revision D and ISO 9001:2015 Certifications

Newly Gained Certifications to Positively Affect Development and Planning for Aerospace and Defense Customers Syncroness, an Alten company based in Westminster, Colorado, earned their quality management certification to AS9100 revision D and ISO 9001:2015 this week for product development. AS9100D, an aerospace and defense standard for quality manageme...

China Shanghu Builds Itself into an International Health Demonstration Zone

On October 25, 2018, the 13th Meeting of the Conference of the Contracting Parties to the Ramsar Convention on Wetlands declared that Changshu was put on the list of the first “International Wetland Cities” in the world, in recognition of its success in the protection of wetland ecology. The award is arguably the most influential on a global scale—su...

Sunday 9th December 2018

CEPI and Imperial College London collaborate on Disease X vaccines project

The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway and Imperial College London have formed an alliance to develop new...Read More... The post CEPI and Imperial College London collaborate on Disease X vaccines project appeared first on Pharmaceutical Technology.

UNSW invests $250m in Health Translation Hub

A new partnership between the NSW Government and UNSW Sydney will see the establishment of a state-of-the-art hub for multidisciplinary medical, education, training and research at the Randwick Hospitals Campus. The university will make an initial investment of up to $250 million in the UNSW Health Translation Hub, which will deliver education, training and research rooms and expanded ambulatory ...

A better understanding of labour market behaviour and success

(Goethe University Frankfurt) Why do some groups behave differently in the labour market than others? What determines labour market success? These questions are at the centre of a new research project by Frankfurt economist and Leibniz Award winner Nicola Fuchs-Schündeln. The project has been made possible by the European Research Council (ERC)'s Consolidator Grant, one of the largest awards fund...

How to build a genetic dose-response portal in 7 years

A meeting was recently convened to discuss a roadmap for understanding the genetics of common diseases (search Twitter for #cdcoxf18). I presented my vision of a genetics dose-response portal (slides here; link to related 2018 ASHG talk here). The organizers (@RachelGLiao, @markmccarthyoxf, @ceclindgren, Rory Collins [Oxford], Judy Cho [New York], @NancyGenetics, @dalygene, @eric_lander) asked pa...

Saturday 8th December 2018

SourceData and BioStudies bring open data sharing to EMBO Press

(EMBO) SourceData from EMBO is an open platform that makes the data in research papers directly searchable. SourceData describes the contents of figures from scientific articles in a standardized, machine-readable format, allowing articles to be searched and interlinked using their data content. In collaboration with BioStudies from EMBL-EBI, a database that aggregates the data files linked to a s...

News digest – lung cancer screening study, 100,000 genomes sequenced, NHS proton beam therapy and a ‘universal cancer blood test’

Science blog Major lung cancer screening study to launch Sky News reports that the UK’s largest lung cancer screening trial is launching in London. In a

Friday 7th December 2018

Living in Space Makes Our Bodies More Susceptible to Infections

Even just 30 days in space can significantly reduce our immune system’s ability to fight infection, suggests a new analysis of mice that spent a month aboard an orbiting spacecraft. The research, which was published December 6 in the journal Federation of American Societies for Experimental Biology, is a recent analysis of data from the Bion-M1 mission, which was a collaborative project carri...

Resaphene Suisse AG: European Patent Office announces patent for tinnitus therapy (news with additional features)

Resaphene Suisse AG / Key word(s): Patent Resaphene Suisse AG: European Patent Office announces patent for tinnitus therapy 07-Dec-2018 / 21:54 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Roggwil, December 7...

Quick Search


News Quicklinks